Publication | Open Access
An approach to personalized cell therapy in chronic complete paraplegia: The Puerta de Hierro phase I/II clinical trial
110
Citations
33
References
2016
Year
Personalized cell therapy with MSCs is safe and leads to clear improvements in clinical aspects and quality of life for patients with complete and chronically established paraplegia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1